2006 Saab 9-7x 4.2i Awd-only 54,876 Orig Miles-best On Ebay-no Reserve on 2040-cars
Boynton Beach, Florida, United States
Vehicle Title:Clear
Engine:4.2L 256Cu. In. l6 GAS DOHC Naturally Aspirated
For Sale By:Dealer
Body Type:Sport Utility
Fuel Type:GAS
Make: Saab
Warranty: Vehicle does NOT have an existing warranty
Model: 9-7x
Trim: 4.2i Sport Utility 4-Door
Options: Leather
Drive Type: AWD
Doors: 4
Mileage: 54,876
Engine Description: 4.2L I6 EFI DOHC 24V
Sub Model: 4dr AWD 4.2i
Exterior Color: Blue
Number of Cylinders: 6
Interior Color: Desert Sand
Saab 9-7x for Sale
- 2008 saab 9-7x awd we finance! clean carfax must see gorgeous lo miles(US $11,975.00)
- 2006 saab 9-7x awd very clean fl suv *dvd *leather* heated seats* no reserve
- 05 saab 9-7x linear 4x4 1-owner very good condition florida carfax certified(US $6,399.00)
- We finance 07 97x altitude nav dvd sunroof leather heated seats xenons tow hitch(US $9,000.00)
- 2006 saab 9-7x 5.3i sport utility 4-door 5.3l
- We finance 06 9-7x 4.2i awd leather heated seats xenons cd changer sunroof 81k(US $9,000.00)
Auto Services in Florida
Youngs` Automotive Service ★★★★★
Winner Auto Center Inc ★★★★★
Vehicles Four Sale Inc ★★★★★
Valvoline Instant Oil Change ★★★★★
USA Auto Glass ★★★★★
Tuffy Auto Service Centers ★★★★★
Auto blog
Saab to reintroduce 9-3 SportCombi as Phoenix development continues
Sun, 27 Apr 2014The saga of Saab goes to show that you can't keep a good automaker down. Founded back in 1947 (the same year, incidentally, as Ferrari, TVR and Maserati defector OSCA), Saab split off from its aerospace division, merged with Scania trucks, was subsequently picked up by General Motors, then pawned off onto Spyker before its current Chinese owners brought it back out of bankruptcy. Now under the auspices of National Electric Vehicle Sweden (NEVS), Saab has official restarted production of the 9-3 sedan, but what are its plans for the future?
In correspondence with Autoblog, NEVS communications director Mikael Ostlund gave us an idea of what to expect. First of all, NEVS is living up to its name by launching an electric version of the 9-3. As we reported a couple of weeks ago, the 9-3 EV currently is undergoing a pilot launch in the Chinese city of Qingdao (which owns part of NEVS) before being rolled out in other markets around the world. But that's not all NEVS has planned for Saab.
The reborn Swedish automaker also plans to relaunch the 9-3 SportCombi to supplement the 9-3 sedan. The wagon version was part of the second-gen 9-3's rollout in the early 2000s, offering increased cargo space and versatility - particularly vital since GM had seen it fit to replace the previous hatchback bodystyle favored by the brand faithful with a more traditional trunked form to lure new buyers into the fold. Although Ostlund confirmed that NEVS has "the option of adding the convertible" back into the lineup, nut has yet to decide on if and when it will do so.
GM recalling 8.4M cars, 8.2M related to ignition problems
Mon, 30 Jun 2014General Motors today announced a truly massive recall covering some 8.4 million vehicles in North America. Most significantly, 8.2 million examples of the affected vehicles are being called back due to "unintended ignition key rotation," though GM spokesperson Alan Adler tells Autoblog that this issue is not like the infamous Chevy Cobalt ignition switch fiasco.
For the sake of perspective, translated to US population, this total recall figure would equal a car for each resident of New Hampshire, Rhode Island, Montana, Delaware, South Dakota, Alaska, North Dakota, the District of Columbia, Vermont and Wyoming. Combined. Here's how it all breaks down:
7,610,862 vehicles in North America being recalled for unintended ignition key rotation. 6,805,679 are in the United States.
NEVS, the company that took over Saab, gets new majority owner
Wed, Jan 16 2019Chinese real estate conglomerate Evergrande Group, a key investor behind troubled electric vehicle startup Faraday Future, has acquired a 51 percent stake in NEVS. That's the Chinese-backed Swedish electric vehicle company that purchased the assets of Saab out of bankruptcy in 2012. The investment by subsidiary Evergrande Health Industry Group was valued at the equivalent of $930 million and is expected to help NEVS develop new EVs. Evergrande said it paid the first installment of $430 million on Jan. 15, with the remainder due by the end of the month. The remaining 49 percent stake is controlled by a holding company controlled by NEVS founder Kai Johan Jiang. "It means that NEVS will get a financial (sic) strong main owner who is very interested in developing our vision about green mobility transport solutions for the future," NEVS CEO Stefan Tilk said in a statement. NEVS, short for National Electric Vehicle Sweden, owns production facilities in Trollhattan, Sweden, and Tianjin, China, with another under construction in Shanghai. In late 2017 the company launched what apparently was limited production of the 9-3 EV, an electric vehicle based — you guessed it — on the old Saab 9-3 platform. The company now says it will be built in Tianjin starting later this year, with components coming from Trollhattan. It boasts a 186-mile range, in-car WiFi and a cabin air filter for the notoriously smoggy Chinese air. It also showed a battery-electric 9-3X concept at CES Asia in 2017, which is likely to be its next model pegged for production. The South China Morning Post, citing local media reports, says two of NEVS' models meet the standards for mass production in China. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. Definitely the best promotional video we've ever seen. Evergrande Health first came to Faraday Future's rescue back in 2017 with a promised $2 billion investment, but the two sides later went into arbitration in Hong Kong over a dispute about money following the first infusion of $800 million, leading the automaker to cut staff and wages last year, casting the future of FF into doubt. At the end of 2018, Faraday announced it had entered into a new restructuring agreement with an Evergrande Health subsidiary that sees them end litigation and jettison the previous investment agreement, taking Evergrande's investment in the company to 32 percent.